CTLA4 and rheumatoid arthritis: In a recent study which investigated the histological and transcriptomic effect of CTLA4-Ig on the synovia of active RA patients despite methotrexate, it was observed that the treatment with this fusion protein significantly downregulated both myeloid leukocytes and T cell activation pathways [34].